APA (7th ed.) Citation

L, M., JS, N., F, V., AR, L., P, M., & JP, F. (2026). Aldosterone antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor monotherapy: An updated meta-analysis. Diabetes, obesity & metabolism, 28(3), 2443. https://doi.org/10.1111/dom.70363

Chicago Style (17th ed.) Citation

L, Mendonça, Neves JS, Vasques-Nóvoa F, Leite AR, Marques P, and Ferreira JP. "Aldosterone Antagonist Combined with a SGLT2 Inhibitor Versus SGLT2 Inhibitor Monotherapy: An Updated Meta-analysis." Diabetes, Obesity & Metabolism 28, no. 3 (2026): 2443. https://doi.org/10.1111/dom.70363.

MLA (9th ed.) Citation

L, Mendonça, et al. "Aldosterone Antagonist Combined with a SGLT2 Inhibitor Versus SGLT2 Inhibitor Monotherapy: An Updated Meta-analysis." Diabetes, Obesity & Metabolism, vol. 28, no. 3, 2026, p. 2443, https://doi.org/10.1111/dom.70363.